Faron Pharmaceuticals Oy (FARN) - Financial and Strategic SWOT Analysis Review

  • ID: 4282132
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Faron Pharmaceuticals
1 of 4
Summary

Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the treatment of acute respiratory distress syndrome (ARDS) an orphan lung disease. Faron's drug platform traumakine prevents vascular leakage through the injured endothelium of several central organs. Its pipeline products concentrates on the therapeutic areas of acute organ traumas, cancer immunotherapy and vascular damage. The company also works in collaboration with academic institutions. Faron Pharma is headquartered in Turku, Finland.

Faron Pharmaceuticals Oy Key Recent Developments

Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer
Sep 06, 2017: Faron Pharmaceuticals: Interim Results for the six months ended 30 June 2017
Apr 19, 2017: Faron Pharmaceuticals: Proposed Board Changes
Mar 29, 2017: Faron Pharmaceuticals: Final Results for the year ended 31 December 2016
Feb 09, 2017: Faron update for 2017

This comprehensive SWOT profile of Faron Pharmaceuticals Oy provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Faron Pharmaceuticals Oy including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Faron Pharmaceuticals Oy - Key Information
  • Faron Pharmaceuticals Oy - Overview
  • Faron Pharmaceuticals Oy - Key Employees
  • Faron Pharmaceuticals Oy - Key Employee Biographies
  • Faron Pharmaceuticals Oy - Key Operational Heads
  • Faron Pharmaceuticals Oy - Major Products and Services
  • Faron Pharmaceuticals Oy - History
  • Faron Pharmaceuticals Oy - Company Statement
  • Faron Pharmaceuticals Oy - Locations And Subsidiaries
  • Faron Pharmaceuticals Oy - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Faron Pharmaceuticals Oy - Business Description
  • Faron Pharmaceuticals Oy - Corporate Strategy
  • Faron Pharmaceuticals Oy - SWOT Analysis
  • SWOT Analysis - Overview
  • Faron Pharmaceuticals Oy - Strengths
  • Faron Pharmaceuticals Oy - Weaknesses
  • Faron Pharmaceuticals Oy - Opportunities
  • Faron Pharmaceuticals Oy - Threats
  • Faron Pharmaceuticals Oy - Key Competitors
Section 3 - Company Financial Performance Charts
  • Faron Pharmaceuticals Oy - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Faron Pharmaceuticals Oy, Key Information
  • Faron Pharmaceuticals Oy, Key Ratios
  • Faron Pharmaceuticals Oy, Share Data
  • Faron Pharmaceuticals Oy, Major Products and Services
  • Faron Pharmaceuticals Oy, History
  • Faron Pharmaceuticals Oy, Key Employees
  • Faron Pharmaceuticals Oy, Key Employee Biographies
  • Faron Pharmaceuticals Oy, Key Operational Heads
  • Faron Pharmaceuticals Oy, Other Locations
  • Faron Pharmaceuticals Oy, Subsidiaries
  • Faron Pharmaceuticals Oy, Key Manufacturing facilities
  • Faron Pharmaceuticals Oy, Key Competitors
  • Faron Pharmaceuticals Oy, SWOT Analysis
  • Faron Pharmaceuticals Oy, Ratios based on current share price
  • Faron Pharmaceuticals Oy, Annual Ratios
  • Faron Pharmaceuticals Oy, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Faron Pharmaceuticals Oy, Performance Chart
  • Faron Pharmaceuticals Oy, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll